US 11866747
Engineered meganucleases that target human mitochondrial genomes
granted A61KA61K38/00A61K48/005
Quick answer
US patent 11866747 (Engineered meganucleases that target human mitochondrial genomes) held by Precision BioSciences, Inc. expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Precision BioSciences, Inc.
- Grant date
- Tue Jan 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K38/00, A61K48/005, A61K9/0019, A61K9/5123